These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2134210)

  • 41. Prevention of diabetes in BB/Wor rats by intrathymic islet injection.
    Koevary SB; Blomberg M
    J Clin Invest; 1992 Feb; 89(2):512-6. PubMed ID: 1737841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
    Kuttler B; Kauert C; Wanka H; Diamantstein T; Hahn HJ
    J Autoimmun; 1996 Jun; 9(3):321-9. PubMed ID: 8816967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glipizide-induced prevention of diabetes and autoimmune events in the BB rat.
    Hosszufalusi N; Reinherz L; Takei S; Chan E; Charles MA
    J Autoimmun; 1994 Dec; 7(6):753-61. PubMed ID: 7888033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to ICA512/IA-2 in rodent models of IDDM.
    Myers MA; Laks MR; Feeney SJ; Mandel TE; Koulmanda M; Bone A; Barley J; Rowley MJ; Mackay IR
    J Autoimmun; 1998 Jun; 11(3):265-72. PubMed ID: 9693975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence that Th1 lymphocytes predominate in islet inflammation and thyroiditis in the BioBreeding (BB) rat.
    Zipris D
    J Autoimmun; 1996 Jun; 9(3):315-9. PubMed ID: 8816966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains.
    Klöting N; Follak N; Klöting I
    Physiol Genomics; 2005 Dec; 24(1):59-64. PubMed ID: 16189279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BioBreeding/Worcester (BB/Wor) rats are deficient in the generation of functional cytotoxic T cells.
    Woda BA; Padden C
    J Immunol; 1987 Sep; 139(5):1514-7. PubMed ID: 3497974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.
    MacKay P; Jacobson J; Rabinovitch A
    J Clin Invest; 1986 Mar; 77(3):916-24. PubMed ID: 3512604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors.
    Kuttler B; Dunger A; Volk HD; Diamantstein T; Hahn HJ
    Diabetologia; 1991 Feb; 34(2):74-7. PubMed ID: 2065851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylactic insulin treatment of diabetes-prone BB/OK rats by application of a sustained release insulin implant.
    Schröder D; Ratke M; Bauer UC; Klöting I; Ziegler B; Schmidt S
    Autoimmunity; 2002 Mar; 35(2):143-53. PubMed ID: 12071437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats.
    Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y
    Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macrophage-mediated islet cell cytotoxicity in BB rats.
    Nagy MV; Chan EK; Teruya M; Forrest LE; Likhite V; Charles MA
    Diabetes; 1989 Oct; 38(10):1329-31. PubMed ID: 2676662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypical characterization of the cells invading pancreatic islets of diabetic BB/OK rats: effect of interleukin 2 receptor-targeted immunotherapy.
    Hahn HJ; Gerdes J; Lucke S; Liepe L; Kauert C; Volk HD; Wacker HH; Brocke S; Stein H; Diamantstein T
    Eur J Immunol; 1988 Dec; 18(12):2037-42. PubMed ID: 3065088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
    Köhler E; Knospe S; Hahn HJ; Roemer KG; Diamantstein T
    Exp Clin Endocrinol; 1989 May; 93(2-3):143-6. PubMed ID: 2673806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coat colour phenotype, leucopenia, and insulin-dependent diabetes mellitus (IDDM) in BB rats.
    Kloeting I; Vogt L
    Diabetes Res; 1990 Sep; 15(1):37-9. PubMed ID: 2132199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on the pathogenesis of type 1 diabetes mellitus--immunochemical studies with monoclonal islet cell surface antibody using hybridization of spleen lymphocytes from non-obese diabetic mice].
    Hari J
    Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):56-68. PubMed ID: 3888686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of lymphocytes and serum from probands before and after manifestation of type 1 (insulin-dependent) diabetes on rat islets in vitro.
    Köhler E; Knospe S; Rjasanowski I; Michaelis D
    Exp Clin Endocrinol; 1988 Dec; 92(2):182-8. PubMed ID: 3072214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3H-thymidine incorporation into islets obtained from prediabetic BB rats.
    Dunger A; Lucke S; Klöting I; Hahn HJ
    Exp Clin Endocrinol; 1989 May; 93(2-3):267-71. PubMed ID: 2673817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of randomization masking diabetes relevant traits in animal experiments.
    Vogt L; Klöting I
    Diabetes Res; 1990 Nov; 15(3):131-5. PubMed ID: 2132206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models.
    Charles MA; Suzuki M; Slater L; Waldeck N; Ong K
    Diabetologia; 1983 Oct; 25(4):348-54. PubMed ID: 6357917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.